Importer of Controlled Substances Application: Adiramedica LLC, 81220-81221 [2020-27509]

Download as PDF 81220 Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices and online at https://eplanning.blm.gov/ eplanning-ui/project/2000251/510. This Notice informs the public of an application submitted by the Fry Fire District, Arizona, for a non-competitive sale and conveyance of the reversionary interests of public land in Cochise County for the District’s Recreation and Public Purposes Act patent 02–85–0038, held since 1985, for a fire station. The conveyance is requested by the Fry Fire District in order to commercially lease its facilities, which is currently prohibited under the Recreation and Public Purposes patent it holds. This would enable the Fry Fire District to commercially lease its facilities, including placement of infrastructure such as cell towers, generating revenue to support its firefighting and emergency medical services to the public. Issuance of the document of conveyance, a new patent, is in accordance with the 1992 Safford District Resource Management Plan (DOI–BLM–AZ–G010–1992–RMP–EIS) and the 1994 Land Tenure Amendment to the Safford District Resource Management Plan (EA/Decision Record No. AZ–040–04–12). Conveyance of the reversionary interest in the land is consistent with applicable Federal and county land use plans and meets the needs of the community. The land is not required for any other Federal purpose. This disposal would not impede access to Federal lands used for recreation, as the Federal lands in the vicinity would continue to have public access. Application Comments: Interested parties may submit comments regarding the specific use proposed in the application or any other factor not directly related to the sale of the reversionary interest. The BLM will review and determine the validity of any adverse comments. In the absence of any adverse comments, the decision will become final. The lands will not be offered for conveyance until a determination of significance and Decision Record have been signed for the completed Environmental Assessment DOI–BLM–AZ–A020–2020– 0029–EA found at: https:// eplanning.blm.gov/eplanning-ui/ project/2000251/510. Before including your address, phone number, email address, or other personal identifying information in your comment, you should be aware that your entire comment, including your personal identifying information, may be made available to the public at any time. While you can ask in your comment to withhold your personal identifying information from public VerDate Sep<11>2014 17:35 Dec 14, 2020 Jkt 253001 review, we cannot guarantee that we will be able to do so. Authority: 43 CFR 2711. Jayme M. Lopez, Field Manager. [FR Doc. 2020–27556 Filed 12–14–20; 8:45 am] BILLING CODE 4310–32–P reference to dug codes 7350 (Marihuana Extract), 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2020–27512 Filed 12–14–20; 8:45 am] DEPARTMENT OF JUSTICE BILLING CODE P Drug Enforcement Administration [Docket No. DEA–755] DEPARTMENT OF JUSTICE Bulk Manufacturer of Controlled Substances Application: Sterling Wisconsin, LLC Drug Enforcement Administration Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Importer of Controlled Substances Application: Adiramedica LLC Sterling Wisconsin, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 16, 2021. Such persons may also file a written request for a hearing on the application on or before February 16, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUMMARY: In accordance with 21 CFR 1301.33(a), this is notice that on October 15, 2020, Sterling Wisconsin, LLC, W130N10497 Washington Drive, Germantown, Wisconsin 53022–4448, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Drug code Controlled substance Marihuana Extract .................... Marihuana ................................ Tetrahydrocannabinols ............ 5-Methoxy-N–NDimethyltryptamine. Oliceridine ................................ Thebaine .................................. Alfentanil .................................. Schedule 7350 7360 7370 7431 I I I I 9245 9333 9737 II II II The company plans to bulk manufacture the listed controlled substances to be commercially sold to registered manufacturers/suppliers. In PO 00000 Frm 00045 Fmt 4703 Sfmt 4703 [Docket No. DEA–753] Drug Enforcement Administration, Justice. AGENCY: ACTION: Notice of application. Adiramedica LLC has applied to be registered as an importer of a basic class of a controlled substance. Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 14, 2021. Such persons may also file a written request for a hearing on the application on or before January 14, 2021. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on October 14, 2020, Adiramedica LLC, 585 Turner Industrial Way, Aston, Pennsylvania 19014, applied to be registered as an importer of the following basic class of a controlled substance: SUPPLEMENTARY INFORMATION: E:\FR\FM\15DEN1.SGM 15DEN1 Federal Register / Vol. 85, No. 241 / Tuesday, December 15, 2020 / Notices Controlled substance Tapentadol .................... Drug code Schedule 9780 II The company plans to import Tapentadol in dosage form for clinical trials. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2020–27509 Filed 12–14–20; 8:45 am] BILLING CODE P DEPARTMENT OF LABOR Employment and Training Administration Labor Certification Process for the Temporary Employment of Aliens in Agriculture in the United States: Adverse Effect Wage Rate for Range Occupations in 2021 Employment and Training Administration (ETA), Labor. ACTION: Notice. AGENCY: Adverse Effect Wage Rate for 2021 The Employment and Training Administration (ETA) of the Department of Labor (Department) is issuing this notice to announce the 2021 Adverse Effect Wage Rate (AEWR) for the employment of temporary or seasonal nonimmigrant foreign workers (H–2A workers) to perform herding or production of livestock on the range. AEWRs are the minimum wage rates the Department has determined must be offered and paid by employers to H–2A workers and workers in corresponding employment so that the wages and working conditions of workers in the United States (U.S.) similarly employed will not be adversely affected. In this notice, the Department announces the annual update of the AEWR for workers engaged in the herding or production of livestock on the range, as required by the methodology established in the Temporary Agricultural Employment of H–2A Foreign Workers in the Herding or Production of Livestock on the Range in the United States, 80 FR 62958, 63067– 63068 (Oct. 16, 2015); 20 CFR 655.211. DATES: The rate is effective January 1, 2021. FOR FURTHER INFORMATION CONTACT: Brian Pasternak, Administrator, Office SUMMARY: VerDate Sep<11>2014 17:35 Dec 14, 2020 Jkt 253001 of Foreign Labor Certification, Employment and Training Administration, Department of Labor, N–5311, 200 Constitution Ave. NW, Washington, DC 20210, Telephone: (202) 513–7350 (this is not a toll-free number). Individuals with hearing or speech impairments may access the telephone number above via TTY by calling the toll-free Federal Information Relay Service at 1–877–889–5627 (TTY/ TDD). SUPPLEMENTARY INFORMATION: The U.S. Citizenship and Immigration Services of the Department of Homeland Security will not approve an employer’s petition for the admission of H–2A nonimmigrant temporary and seasonal agricultural workers in the U.S. unless the petitioner has received an H–2A labor certification from the Department. The H–2A labor certification provides that (1) there are not sufficient U.S. workers who are able, willing, and qualified and who will be available at the time and place needed to perform the labor or services involved in the petition; and (2) the employment of the foreign worker(s) in such labor or services will not adversely affect the wages and working conditions of workers in the U.S. similarly employed. 8 U.S.C. 1101(a)(15)(H)(ii)(a), 1184(c)(1), and 1188(a); 8 CFR 214.2(h)(5); 20 CFR 655.100. The Department’s H–2A regulations covering the herding or production of livestock on the range (H–2A Herder Rule) at 20 CFR 655.210(g) and 655.211(a)(1) provide that employers must offer, advertise in recruitment, and pay each worker employed under 20 CFR 655.200–655.235 a wage that is at least the highest of (1) the monthly AEWR, (2) the agreed-upon collective bargaining wage, or (3) the applicable minimum wage imposed by federal or state law or judicial action. Further, when the monthly AEWR is adjusted during a work contract and is higher than both the agreed-upon collective bargaining wage and the applicable minimum wage imposed by federal or state law or judicial action in effect at the time the work is performed, the employer must pay that adjusted monthly AEWR upon publication by the Department in the Federal Register. 20 CFR 655.211(a)(2). As provided in 20 CFR 655.211(c)(2) of the H–2A Herder Rule, the monthly AEWR for range occupations in all states for a calendar year is based on the monthly AEWR for the previous calendar year, adjusted by the Employment Cost Index (ECI) for wages PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 81221 and salaries published by the Bureau of Labor Statistics for the preceding annual period. The 12-month change in the ECI for wages and salaries of private industry workers between September 2019 and September 2020 was 2.7 percent, resulting in a monthly AEWR for range occupations in effect for 2021 of $1,727.75.1 The national monthly AEWR rate for all range occupations in the H–2A program in 2021 is calculated by multiplying the monthly AEWR for calendar year 2020 by the October 2020 ECI adjustment ($1,682.33 × 1.027 = $1,727.75) or $1,727.75. Accordingly, any employer certified or seeking certification for range workers must pay each worker a wage that is at least the highest of the monthly AEWR of $1,727.75, the agreed-upon collective bargaining wage, or the applicable minimum wage imposed by federal or state legislation or judicial action at the time work is performed on or after the effective date of this notice. John Pallasch, Assistant Secretary for the Employment and Training Administration. [FR Doc. 2020–27468 Filed 12–14–20; 8:45 am] BILLING CODE 4510–FP–P DEPARTMENT OF LABOR Agency Information Collection Activities; Submission for OMB Review; Comment Request; Job Corps Hall of Fame and Successful Graduate Nomination Office of the Secretary, Department of Labor. AGENCY: Notice of availability; request for comments. ACTION: The Department of Labor (DOL) is submitting this Employment and Training Administration (ETA)sponsored information collection request (ICR) to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995 SUMMARY: 1 The regulation at 20 CFR 655.211(c)(2) states that the monthly AEWR is calculated based on the ECI for wages and salaries ‘‘for the preceding October—October period.’’ This regulatory language was intended to identify the Bureau of Labor Statistics’ October publication of ECI for wages and salaries, which presents data for the September— September period. Accordingly, the most recent 12month change in the ECI for private sector workers published on October 30, 2020, by the Bureau of Labor Statistics was used for establishing the monthly AEWR under the regulations. See https:// www.bls.gov/news.release/archives/eci_ 10302020.pdf. The ECI for private sector workers was used rather than the ECI for all civilian workers given the characteristics of the H–2A herder workforce. E:\FR\FM\15DEN1.SGM 15DEN1

Agencies

[Federal Register Volume 85, Number 241 (Tuesday, December 15, 2020)]
[Notices]
[Pages 81220-81221]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27509]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-753]


Importer of Controlled Substances Application: Adiramedica LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Adiramedica LLC has applied to be registered as an importer of 
a basic class of a controlled substance. Refer to Supplemental 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration on or before January 14, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before January 14, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on October 14, 2020, Adiramedica LLC, 585 Turner 
Industrial Way, Aston, Pennsylvania 19014, applied to be registered as 
an importer of the following basic class of a controlled substance:

[[Page 81221]]



------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tapentadol.............................     9780  II
------------------------------------------------------------------------

    The company plans to import Tapentadol in dosage form for clinical 
trials. No other activity for this drug code is authorized for this 
registration.
    Approval of permit applications will occur only when the 
registrant's activity is consistent with what is authorized under 21 
U.S.C. 952(a)(2). Authorization will not extend to the import of Food 
and Drug Administration-approved or non-approved finished dosage forms 
for commercial sale.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-27509 Filed 12-14-20; 8:45 am]
BILLING CODE P